Guangzhou Baiyunshan Pharmaceutical Holdings
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd is a Chinese multinational pharmaceutical and healthcare enterprise specializing in the research, development, manufacturing, and distribution of traditional Chinese medicines, Western prescription medicines, generic drugs, medical devices, and health food products. The company operates extensive pharmaceutical manufacturing plants, traditional medicine research institutes, and retail pharmacy chains across China. Its core business operations encompass pharmaceutical drug production, traditional medicine formulation, medical distribution, and healthcare retail services. Revenue is derived primarily from the wholesale and retail sale of pharmaceutical drugs, health supplements, and medical supplies. Guangzhou Baiyunshan Pharmaceutical Holdings holds a dominant market position in pharmaceutical manufacturing and traditional Chinese medicine in China. The company is headquartered in Guangzhou, Guangdong Province, China, and its shares trade on the Shanghai Stock Exchange and the Stock Exchange of Hong Kong.
3 of the funds FundTelligence covers report a position in Guangzhou Baiyunshan Pharmaceutical Holdings.
- Legal name
- Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
- Sector
- Health Care
- Country
- China
- Funds holding it
- 3
Funds holding Guangzhou Baiyunshan Pharmaceutical Holdings
- KLP AksjeFremvoksende Markeder Flerfaktor — KLP · 0.31 % (full portfolio disclosed, June 2026)
- Handelsbanken Emerging Markets Index — Handelsbanken · 0.01 % (full portfolio disclosed, September 2026)
- Handelsbanken Global Index Criteria — Handelsbanken · 0.0 % (full portfolio disclosed, September 2026)